HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by McDowell, J. H. Articles by Hargrave, P. A. Search for Related Content PubMed PubMed Citation Articles by McDowell, J. H. Articles by Hargrave, P. A.

Activation of Arrestin: Requirement of Phosphorylation as the Negative Charge on Residues in Synthetic Peptides from the Carboxyl-Terminal Region of Rhodopsin

¹ From the Departments of Ophthalmology and ³ Biochemistry and Molecular Biology, University of Florida, Gainesville; and ² Biological Sciences, University of Maryland, Baltimore County.

PURPOSE. To determine whether substitution of the potential phosphorylation sites of bovine rhodopsin’s carboxyl-terminal region with the acidic residues aspartic acid, glutamic acid, or cysteic acid promotes the activation of arrestin.

METHODS. Three peptide analogues of the 19-residue carboxyl-terminal region of rhodopsin (330-348) were synthesized: the fully phosphorylated peptide (7P-peptide), the peptide with all potential phosphorylation sites substituted with glutamic acid (7E-peptide), and the peptide with the phosphorylation sites substituted with cysteic acid (7Cya-peptide). The peptides were tested in assays in which the 7P-peptide had previously been shown to have an effect. Rhodopsin with glutamic acid (Etail) or aspartic acid (Dtail) substituted for the phosphorylation sites in rhodopsin were constructed and expressed in COS-7 cells and tested in an in vitro assay.

RESULTS. Earlier work has demonstrated that the 7P-peptide activates arrestin, showing induction of arrestin binding to light-activated unphosphorylated rhodopsin, inhibition of the light-induced phosphodiesterase (PDE) activity in rod outer segments (ROS) with excess arrestin, increase in the initial rapid proteolysis of arrestin by trypsin, and enhanced reactivity of one of arrestin’s sulfhydryl groups with inhibition of the reactivity of another. None of these effects was observed in the presence of 7E-peptide or 7Cya-peptide. The 7Cya-peptide inhibited the PDE activity in ROS, but the same effect was observed both in the presence and the absence of excess arrestin. Because none of the other effects was observed with the 7Cya-peptide, the authors conclude that the 7Cya-peptide does not activate arrestin, but acts, probably nonspecifically, through some other part of the transduction system. Considerable arrestin-mediated rhodopsin inactivation was observed with both the Etail and the Dtail mutant, although these substitutions did not yield rhodopsins that were equivalent to phosphorylated rhodopsin.

CONCLUSIONS. These results, taken together, suggest that the negative charge due to phosphates in the carboxyl-terminal region of rhodopsin are required for the full activation of arrestin and that acidic amino acids (carboxyl and sulfonic) do not mimic the negative charge of phosphorylated residues.

This article has been cited by other articles:

				K. N. Nobles, Z. Guan, K. Xiao, T. G. Oas, and R. J. Lefkowitz The Active Conformation of beta-Arrestin1: DIRECT EVIDENCE FOR THE PHOSPHATE SENSOR IN THE N-DOMAIN AND CONFORMATIONAL DIFFERENCES IN THE ACTIVE STATES OF beta-ARRESTINS1 AND -2 J. Biol. Chem., July 20, 2007; 282(29): 21370 - 21381. [Abstract] [Full Text] [PDF]

				K. Xiao, S. K. Shenoy, K. Nobles, and R. J. Lefkowitz Activation-dependent Conformational Changes in {beta}-Arrestin 2 J. Biol. Chem., December 31, 2004; 279(53): 55744 - 55753. [Abstract] [Full Text] [PDF]

				O. G. Kisselev, M. A. Downs, J. H. McDowell, and P. A. Hargrave Conformational Changes in the Phosphorylated C-terminal Domain of Rhodopsin during Rhodopsin Arrestin Interactions J. Biol. Chem., December 3, 2004; 279(49): 51203 - 51207. [Abstract] [Full Text] [PDF]

				P. G.-d. Arco, K. Maki, and K. Georgopoulos Phosphorylation Controls Ikaros's Ability To Negatively Regulate the G1-S Transition Mol. Cell. Biol., April 1, 2004; 24(7): 2797 - 2807. [Abstract] [Full Text] [PDF]

				I. Ranchon, M. M. LaVail, Y. Kotake, and R. E. Anderson Free Radical Trap Phenyl-N-tert-Butylnitrone Protects against Light Damage But Does Not Rescue P23H and S334ter Rhodopsin Transgenic Rats from Inherited Retinal Degeneration J. Neurosci., July 9, 2003; 23(14): 6050 - 6057. [Abstract] [Full Text] [PDF]

				F. Huttenrauch, A. Nitzki, F.-T. Lin, S. Honing, and M. Oppermann beta -Arrestin Binding to CC Chemokine Receptor 5 Requires Multiple C-terminal Receptor Phosphorylation Sites and Involves a Conserved Asp-Arg-Tyr Sequence Motif J. Biol. Chem., August 16, 2002; 277(34): 30769 - 30777. [Abstract] [Full Text] [PDF]

				A. Dinculescu, J. H. McDowell, S. A. Amici, D. R. Dugger, N. Richards, P. A. Hargrave, and W. C. Smith Insertional Mutagenesis and Immunochemical Analysis of Visual Arrestin Interaction with Rhodopsin J. Biol. Chem., March 29, 2002; 277(14): 11703 - 11708. [Abstract] [Full Text] [PDF]

				R. M. Potter, T. A. Key, V. V. Gurevich, L. A. Sklar, and E. R. Prossnitz Arrestin Variants Display Differential Binding Characteristics for the Phosphorylated N-Formyl Peptide Receptor Carboxyl Terminus J. Biol. Chem., March 8, 2002; 277(11): 8970 - 8978. [Abstract] [Full Text] [PDF]